We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+12.66%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.6B
AUM Growth
+$492M
Cap. Flow
+$29.6M
Cap. Flow %
0.64%
Top 10 Hldgs %
30.7%
Holding
1,209
New
99
Increased
196
Reduced
300
Closed
114

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$49.2M
2
EXPD icon
Expeditors International
EXPD
+$25M
3
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
+$17.2M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$7.71M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.24M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$32.4M
2
LHX icon
L3Harris
LHX
+$11.9M
3
V icon
Visa
V
+$7.78M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$5.6M

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Healthcare 17.94%
3 Financials 12.59%
4 Consumer Discretionary 10.3%
5 Industrials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRG icon
1051
NRG Energy
NRG
$29.8B
$1K ﹤0.01%
25
– –
OM icon
1052
Outset Medical
OM
$74.9M
$1K ﹤0.01%
+1
New +$740
PIPR icon
1053
Piper Sandler
PIPR
$5.14B
$1K ﹤0.01%
24
– –
POLA icon
1054
Polar Power
POLA
$5.28M
$1K ﹤0.01%
51
+34
+200% +$1.2K
RCL icon
1055
Royal Caribbean
RCL
$78.7B
$1K ﹤0.01%
15
– –
SCHP icon
1056
Schwab US TIPS ETF
SCHP
$16.3B
$1K ﹤0.01%
16
– –
SCHX icon
1057
Schwab US Large- Cap ETF
SCHX
$70.9B
$1K ﹤0.01%
54
– –
SNPS icon
1058
Synopsys
SNPS
$71.5B
$1K ﹤0.01%
2
– –
TTWO icon
1059
Take-Two Interactive
TTWO
$43B
$1K ﹤0.01%
5
-16
-76% -$2.79K
UA icon
1060
Under Armour Class C
UA
$2.92B
$1K ﹤0.01%
50
– –
UAA icon
1061
Under Armour
UAA
$3B
$1K ﹤0.01%
50
– –
VYGR icon
1062
Voyager Therapeutics
VYGR
$187M
$1K ﹤0.01%
500
-2,000
-80% -$6.82K
WKHS icon
1063
Workhorse Group
WKHS
$29.5M
– –
0
– –
WTW icon
1064
Willis Towers Watson
WTW
$27.9B
$1K ﹤0.01%
5
– –
WYNN icon
1065
Wynn Resorts
WYNN
$10.1B
$1K ﹤0.01%
10
– –
XMTR icon
1066
Xometry
XMTR
$4.77B
$1K ﹤0.01%
+16
New +$823
CPAY icon
1067
Corpay
CPAY
$24.2B
$1K ﹤0.01%
4
– –
MKFG
1068
DELISTED
Markforged Holding Corporation
MKFG
$1K ﹤0.01%
10
– –
ASTR
1069
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$1K ﹤0.01%
8
– –
TSP
1070
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$1K ﹤0.01%
30
– –
ECOL
1071
DELISTED
US Ecology, Inc.
ECOL
$1K ﹤0.01%
30
– –
ABEV icon
1072
Ambev
ABEV
$47.3B
– –
-1,400
Closed -$4K
AIV
1073
Aimco
AIV
$380M
– –
-23
Closed –
AMED
1074
DELISTED
Amedisys
AMED
– –
-8
Closed -$1K
AMWL icon
1075
American Well
AMWL
$181M
– –
-110
Closed -$20K
41 42
43
44 45

Similar funds

AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return

HM Payson & Co's Q4 2021 Portfolio in Review

As of Q4 2021, HM Payson & Co held 1,209 positions worth $4.6B, up 12% from $4.11B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HM Payson & Co's Q4 2021 filing shows 99 new, 196 increased, 300 reduced and 114 closed positions. Its largest new stake was Peoples Bancorp: 23,400 shares worth $744K. The largest sale was Amgen, an estimated $32.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q4 2021 buy was Peoples Bancorp: 23,400 shares worth $744K.
  • HM Payson & Co added most to CVS Health in Q4 2021, an estimated $49.2M increase.
  • HM Payson & Co's biggest Q4 2021 reduction was Amgen, cutting an estimated $32.4M.
  • HM Payson & Co fully exited Invesco BulletShares 2021 Corporate Bond ETF in Q4 2021, selling an estimated $5.01M.
  • HM Payson & Co's ten largest holdings make up 31% of its $4.6B portfolio in Q4 2021.
  • HM Payson & Co opened 99 new positions and closed 114 in Q4 2021.
  • HM Payson & Co's portfolio value rose 12% quarter-over-quarter to $4.6B.

Based on HM Payson & Co's 13F filing for Q4 2021, filed 15 Feb 2022.